IDEXX Laboratories, Inc. (IDXX)

Veterinary diagnostics: tests, analyzers, labs, software. Read October 19, 2026 from the annual report for the period ending December 31, 2025, filed February 20, 2026. Ranked 33 of the 95 Healthcare companies read so far, by the share within reach now.

IDEXX states approximately 11,000 regular full-time and part-time employees in about 34 countries at December 31, 2025, with products at 59% of revenue and services at 41% and no count by kind of work, so the diagnostic kits and analyzers, the reference laboratories and the practice software are split by description (c).

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 22% now, 38% at the end of 2027, 45% at the end of 2028, 49% at the end of 2030. By the patterns, the work is about 49% desk work, 17% people work and 34% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 52% of the working time stays with people (conversation, in-person and hands-on work), 37% becomes checking a model's work and 8% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

11,000 employees as of December 31, 2025 (stated). The filing counts employees in about 34 countries without a U.S. share; U.S. revenue is 61%.

The filing: “As of December 31, 2025, we had approximately 11,000 regular full-time and part-time employees in approximately 34 countries around the world, and men and women represented 41% and 59%, respectively, of our global employee population.”

The workforce as industry patterns

What the filing says about the workforce: Approximately 11,000 regular full-time and part-time employees in about 34 countries; 59% women; a growing companion animal diagnostics field organization; no union share is stated.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Pharmaceutical and Medicine Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five.

• Johnson & Johnson (JNJ, 140,800 employees)19% now, 39% by 2028
• Thermo Fisher Scientific Inc. (TMO, 125,000 employees)20% now, 49% by 2028
• Merck & Co., Inc. (MRK, 75,000 employees)19% now, 41% by 2028
• Pfizer Inc. (PFE, 75,000 employees)19% now, 41% by 2028
• AbbVie Inc. (ABBV, 57,000 employees)19% now, 41% by 2028
• Eli Lilly and Company (LLY, 50,000 employees)19% now, 41% by 2028
• Bristol-Myers Squibb Company (BMY, 32,500 employees)19% now, 41% by 2028
• Amgen Inc. (AMGN, 31,500 employees)19% now, 41% by 2028

What the filing says about AI

38 sentences in the filing name AI. The filing names proprietary AI capabilities in the image capture systems of its point-of-care analyzers, among 38 mentions.

• “GLOSSARY OF TERMS AND SELECTED ABBREVIATIONS Term/Abbreviation Definition AI Artificial intelligence AOCI Accumulated other comprehensive income or loss ASC Accounting Standards Codification ASU Accounting Standards Update CAG Companion Animal Group, a reporting segment that provides veterinarians diagnostic products and services and information management solutions that enhance the health and...”
• “CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This Annual Report on Form 10-K for the year ended December 31, 2025, contains statements which, to the extent they are not statements of historical fact, constitute "forward-looking statements." Such forward-looking statements about our business and expectations within the meaning of the Private Securities Litigation Reform Act of 1995...”
• “Several of these point-of-care analyzers, including the Catalyst One Chemistry analyzer, ProCyte One hematology analyzer, SediVue Dx Analyzer, and IDEXX inVue Dx Cellular Analyzer, utilize proprietary AI capabilities in their image capture systems to analyze samples.”
• “This platform features proprietary AI capabilities.”
• “The IDEXX inVue Dx Cellular Analyzer uses advanced optics and AI technology in a slide-free, load-and-go platform.”

Its annual reports, year by year

Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector

• Fiscal 20210median 0
• Fiscal 20220median 0
• Fiscal 202326median 1
• Fiscal 202429median 4
• Fiscal 202538median 10

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• No count by kind of work: the four shares are by description (c); the data service's segment table is by revenue type.
• The U.S. share is not stated.

Source: the company's annual report on EDGAR, accession 0000874716-26-000038, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.